Coronary Stents Market Worth Around $16.88 Billion By 2025

Acumen Research and Consulting, Recently Published Report titled “Coronary Stents Market Size, Share, Trends, Growth Opportunities and Forecast, 2018 - 2025”.

June 12, 2019 /MarketersMedia/ —

The global coronary stents market is expected to reach the market value of around $16.88 billion by 2025 and is expected to grow at a CAGR of around 7% in terms of revenue during the period 2018 - 2025.

Coronary stents are small stretchy tube-like devices that is used to prevent blockage by expanding the arteries of the patient. Due to the build-up of plaque, a coronary stent is inserted into the artery of a patient suffering from a coronary disease. It helps in reducing chest pain and the chance of heart attack; and it is used for widening the narrowed arteries. Rising dominance towards the coronary artery diseases, rising geriatric population, and technological advancements are attributed to the growth of coronary stents market.

Furthermore, the growth of coronary stents market is hampered due to the stringent regulations & approval of the stents. For the clinical trial safety and accuracy of the stents, they are checked at each stage. There are different stages of government regulation for manufacturing the coronary stents, where each stents undergoes an examination for the safety and accuracy. There are important rules that manufacturers have to follow and cross checked at each and every stage of the clinical trial. These factors are likely to restrain the market growth in forecasted period.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1416

Drug Eluting Stent (DES) Is Dominating the Market Growth

Stenting for coronary applications has been extensively adopted in clinical trials and is associated with improved outcomes. In coronary stents market, currently, drug-eluting stent (DES) is dominating the market growth, as DES is considered the standard of treatment and will continue to do so throughout the forecasted period. The DES market is accounted for nearly 80% of market shares. DES have the larger market sales which can be attributed to physicians clinical experiences and expertise in using these stents, enhanced outcomes, and also reduced need for repeated intervention. Furthermore, bare metal stents are used where the patient is not in a good condition to receive drug-eluting stent, in case where the patient is planning to undergo other major surgeries in the near future.

The Development Of Bio-Absorbable Is Curbing The Market Growth

Bio-absorbable stents were innovated as an alteration due to growing concerns of stents for lifetime or until surgically eliminated. Bio-absorbable stents are similar in function to DES and BMS, but are different by manufacturing. Bio-absorbable is manufactured by using natural dissolving material that has capacity to degrade over a short period of time. Usually, the base materials used for manufacturing this stents are metal and polymers. Furthermore, metals based stents include magnesium, iron, zinc with their alloy while polymer based stents are made by using poly L-lacitde as base material. Therefore, there have been some technical difficulties in implantation of bio-absorbable that has restricted its global use.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/coronary-stents-market

The Largest Application of Coronary Stents Is Angina

Angina is chest pain, which is caused by reduction of blood flow to the heart muscles. Mostly it is not a life threatening, but it’s a strong indicator for patient, can be at risk of a heart attack or stroke. Globally, angina is the largest application of coronary stents and approximately, 80% of the total sales are generated by its application in angina. The angina application segment is expected to remain dominant throughout the forecasted period owing to rising patient population worldwide.

Insights on Market Segments

Global coronary stents market is segmented by type, application and geography. Based on different types, the market is segmented into bare metal stents, drug eluting stent, and bio-absorbable stent. Also, application is further bifurcated into Angina, and Myocardial Infarction. Based on geography market is further classified into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Geographically segmented Coronary Stents Market

North America held the largest market share in 2017 and is expected to dominate the market through the forecasting phase. Countries in North America are well planned for remuneration program, sophisticated healthcare system, high healthcare expenditure, and large number of population held a considerable share in coronary stent market, globally. The latest trends of growing popularity of bio-absorbable stents have been observed in North America coronary stents market. Some of the major companies in this region is involved in coronary stents market are Abbott Laboratories, Medtronic, Inc, Becton Disckinson and Boston Scientific Corporation. Furthermore, in forecasted period Asia Pacific region will exhibit beneficial growth rate. Especially, countries like China and India are will show sustained growth due to economic developments and rebuild of government.

Some of the key players operating in the global coronary stents market, profiled in the report include Abbott Vascular, Medtronic, Boston Scientific, B. Braun Melsungen AG, Biotronik SE & Co. KG, Terumo, Stentys SA, Becton Dickinson and Co., Cook Group, SMT and Micro Port among others..

Chapter 1. Coronary Stents Summary

Chapter 2. Coronary Stents Market Overview

2.1 Coronary Stents Product Overview
2.2 Coronary Stents Market Segment by Type
2.2.1 Global Coronary Stents Sales Comparison by Types (2013-2025)
2.2.2 Global Coronary Stents Sales Market Share by Types in 2017
2.2.3 Drug-eluting Stents
2.2.4 Bare Metal Stents
2.2.5 Bio-absorbable Stents
2.3 Global Coronary Stents Segment by Applications
2.3.1 Global Coronary Stents Sales Comparison by Applications (2013-2025)
2.3.2 Angina
2.3.3 Myocardial Infarction
2.4 Global Coronary Stents Market by Regions
2.4.1 Global Coronary Stents Market Size by Regions
2.4.2 North America Coronary Stents Status and Prospect (2013-2025)
2.4.3 Asia-Pacific Coronary Stents Status and Prospect (2013-2025)
2.4.4 Europe Coronary Stents Status and Prospect (2013-2025)
2.4.5 South America Coronary Stents Status and Prospect (2013-2025)
2.4.6 Middle East and Africa Coronary Stents Status and Prospect (2013-2025)
2.5 Global Coronary Stents Market Size
2.5.1 Global Coronary Stents Revenue Status and Outlook (2013-2025)
2.5.2 Global Coronary Stents Sales Status and Outlook (2013-2025)

Chapter 3. Global Coronary Stents Market Competition by Manufacturers

3.1 Global Coronary Stents Sales by Manufacturers (2013-2018)
3.2 Global Coronary Stents Revenue and Share by Manufacturers (2013-2018)
3.3 Global Coronary Stents Average Price by Manufacturers (2013-2018)
3.4 Manufacturers Coronary Stents Manufacturing Base Distribution, Sales Area, Product Types
3.5 Coronary Stents Market Competitive Situation and Trends
3.5.1 Coronary Stents Market Concentration Rate
3.5.2 Coronary Stents Market Share of Top 5 and Top 10 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4. Global Coronary Stents Sales, Revenue by Regions

4.1 Global Coronary Stents Sales and Market Share by Regions (2013-2018)
4.2 Global Coronary Stents Revenue by Regions (2013-2018)
4.3 Global Coronary Stents Sales, Revenue, Price and Gross Margin (2013-2018)
4.4 North America Coronary Stents Sales, Revenue, Price and Gross Margin (2013-2018)
4.5 Europe Coronary Stents Sales, Revenue, Price and Gross Margin (2013-2018)
4.6 Asia-Pacific Coronary Stents Sales, Revenue, Price and Gross Margin (2013-2018)
4.7 South America Coronary Stents Sales, Revenue, Price and Gross Margin (2013-2018)
4.8 Middle East and Africa Coronary Stents Sales, Revenue, Price and Gross Margin (2013-2018)

Chapter 5. Global Coronary Stents Sales, Revenue, Price Trend by Types

5.1 Global Coronary Stents Sales by Types (2013-2018)
5.1.1 Drug-eluting Stents
5.1.2 Bare Metal Stents
5.1.3 Bio-absorbable Stents
5.2 Global Coronary Stents Revenue by Types (2013-2018)
5.3 Global Coronary Stents Price by Type (2013-2018)
5.4 Global Coronary Stents Sales Growth by Type (2013-2018)

Chapter 6. Global Coronary Stents Market Analysis by Applications

6.1 Global Coronary Stents Sales and Market Share by Applications (2013-2018)
6.1.1 Angina
6.1.2 Myocardial Infarction

Chapter 7. Global Coronary Stents Manufacturers Profiles/Analysis

7.1 Abbott Vascular
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Coronary Stents Product Category, End Users and Specification
7.1.3 Abbott Vascular Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Medtronic
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Coronary Stents Product Category, Application and Specification
7.2.3 Medtronic Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Boston Scientific
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Coronary Stents Product Category, End Uses and Specification
7.3.3 Boston Scientific Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Biosensors
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Coronary Stents Product Category, End Uses and Specification
7.4.3 Biosensors Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Terumo
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Coronary Stents Product Pipeline
7.5.3 Terumo Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.5.4 Main Business/Business Overview
7.6 MicroPort
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Coronary Stents Product Category, End Uses and Specification
7.6.3 MicroPort Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Lepu Medical
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Coronary Stents Product Category, End Uses and Specification
7.7.3 Lepu Medical Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.7.4 Main Business/Business Overview
7.8 B. Braun
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Coronary Stents Product Category, End Uses and Specification
7.8.3 B.Braun Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Atrium Medical
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Coronary Stents Product Category, End Uses and Specification
7.9.3 Atrium Medical Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.9.4 Main Business/Business Overview
7.10 SINOMED
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Coronary Stents Product Category, End Uses and Specification
7.10.3 SINOMED Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.10.4 Main Business/Business Overview
7.11 LBC
7.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.11.2 Coronary Stents Product Category, End Uses and Specification
7.11.3 LBC Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.11.4 Main Business/Business Overview
7.12 Cordis Corporation
7.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.12.2 Coronary Stents Product Category, End Uses and Specification
7.12.3 Cordis Corporation Coronary Stents Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
7.12.4 Main Business/Business Overview

Chapter 8. Coronary Stents Manufacturing Cost Analysis

8.1 Coronary Stents Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses

Chapter 9. Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Coronary Stents Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Coronary Stents Major Manufacturers in 2017
9.4 Downstream Buyers

Chapter 10. Marketing Strategy Analysis, Distributors and Market Effect Factors

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.1.1 Pricing for Market Penetration
10.2.1.2 Price Skimming
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11. Market Effect Factors Analysis

11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12. Global Coronary Stents Market Forecast

12.1 Global Coronary Stents Sales, Revenue Forecast (2018-2025)
12.1.1 Global Coronary Stents Sales and Growth Rate Forecast (2018-2025)
12.1.2 Global Coronary Stents Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Coronary Stents Price and Trend Forecast (2018-2025)
12.2 Global Coronary Stents Sales and Revenue Forecast by Regions (2018-2025)
12.2.1 North America Coronary Stents Sales and Revenue Forecast (2018-2025)
12.2.2 Europe Coronary Stents Sales and Revenue Forecast (2018-2025)
12.2.3 Asia-Pacific Coronary Stents Sales and Revenue Forecast (2018-2025)
12.2.4 South America Coronary Stents Sales and Revenue Forecast (2018-2025)
12.2.5 Middle East and Africa Coronary Stents Sales and Revenue Forecast (2018-2025)
12.3 Global Coronary Stents Sales, Revenue, Price Forecast by Type (2018-2025)
12.3.1 Drug-eluting Stents
12.3.2 Bare Metal Stents
12.3.3 Bio-absorbable Stents
12.4 Global Coronary Stents Sales Forecast by Application (2018-2025)
12.4.1 Angina
12.4.2 Myocardial Infarction

Chapter 13. Research Findings and Conclusion

Chapter 14. Methodology and Data Source

14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1416

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1416

If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

For Latest Update Follow Us:

https://twitter.com/AcumenRC

https://www.facebook.com/acumenresearchandconsulting

https://www.linkedin.com/company/acumen-research-and-consulting/

Browse More Press Releases: http://www.amecoresearch.com/press-releases

Contact Info:
Name: Frank Wilson
Email: Send Email
Organization: Acumen Research and Consulting
Website: https://www.acumenresearchandconsulting.com

Source URL: https://marketersmedia.com/coronary-stents-market-worth-around-1688-billion-by-2025/523465

Source: MarketersMedia

Release ID: 523465

Latest News

Putin engineers shakeup that could keep him in power longer

Jul 5, 2020

MOSCOW — President Vladimir Putin engineered a surprise shakeup of Russia's leadership Wednesday, proposing changes to the constitution that could keep him in power well past the end of his term in 2024. Prime Minister Dmitry Medvedev resigned his post after Putin announced the proposed constitutional amendments. Putin kept his longtime ally in the Kremlin's leadership structure, appointing him to the newly created post of deputy head of the presidential Security Council. The shakeup sent shock waves through Russia's political elites who were left pondering what Putin's intentions were and speculating about future Cabinet appointments. Putin’s proposed constitutional reforms, announced...

Sultan Qaboos bin Said, who modernized Oman, dies at 79

Jul 5, 2020

DUBAI, United Arab Emirates — Oman’s Sultan Qaboos bin Said, the Mideast's longest-ruling monarch who seized power in a 1970 palace coup and pulled his Arabian sultanate into modernity while carefully balancing diplomatic ties between adversaries Iran and the U.S., has died. He was 79. The British-educated, reclusive sultan reformed a nation that was home to only three schools and harsh laws banning electricity, radios, eyeglasses and even umbrellas when he took the throne. Under his reign, Oman became known as a welcoming tourist destination and a key Mideast interlocutor, helping the U.S. free captives in Iran and Yemen and...

On streets of Tehran, relief for now at no wider conflict

Jul 5, 2020

TEHRAN, Iran — Iranian newspapers proclaimed the country's attack on U.S. forces in Iraq to be "a dark night for Americans," and Washington's "first admission of failure in history." On the bustling streets of Tehran, however, there was relief Thursday that neither side appeared primed for war. “War is not something like the ‘Call of Duty’ game," said Dara Shojaei, a 23-year-old architecture student. “It's not a game you can play to win. There's no winner.” But with the relief came some mixed feelings about how far Iran should go to avenge the killing of Revolutionary Guard Gen. Qassem Soleiman,...

Stocks rise as China confirms trade deal signing next week

Jul 5, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

Soleimani, a general who became Iran icon by targeting US

Jul 5, 2020

TEHRAN, Iran — For Iranians whose icons since the Islamic Revolution have been stern-faced clergy, Maj. Gen. Qassem Soleimani widely represented a figure of national resilience in the face of four decades of U.S. pressure. For the U.S. and Israel, he was a shadowy figure in command of Iran's proxy forces, responsible for fighters in Syria backing President Bashar Assad and for the deaths of American troops in Iraq. Solemani survived the horror of Iran’s long war in the 1980s with Iraq to take control of the Revolutionary Guard’s elite Quds Force, responsible for the Islamic Republic’s foreign campaigns. Relatively...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com